Skip to Content
Hae Menu

SABCS2020: Robust survival outcome in HER2 positive metastatic breast cancer

Hear Shanu Modi, Memorial Sloan Kettering Cancer Center, New York, presents the updated results of treatment with trastuzumab deruxtecan in patients with HER2 positive metastatic breast cancer.

Avaa artikkeli

Jos olet lääkäri, sairaanhoitaja tai muu terveydenhuollon ammattilainen, voit käyttää koko artikkelia luomalla profiilin BestPractice Nordic -sivustolle.

Related

Highlights from ASCO GU 2021 by Thomas Powles, Barts Cancer Centre, London

/ Thomas Powles
ASCO GU21 Play the Video 4:41

Pembrolizumab plus chemotherapy provided durable clinical benefit in patients with metastatic squamous NSCLC

/ Martin Reck
WCLC20 Play the Video 8:48

Pembrolizumab with chemo-radiation therapy showed promising antitumor activity in unresectable, locally advanced, stage III NSCLC

/ Martin Reck
WCLC20 Play the Video 7:17
Back to top